| http://www.w3.org/ns/prov#value | - This finding can be particularly worrisome in settings such as Sub-Saharan Africa and Asia, where there is a constrained access to powerful anti-HBV drugs, virological monitoring, and a high prevalence of HBV-infection, say authors Fabien Zoulim (Lyon University, France) and colleagues.
|
